期刊文献+

p53、p16在宫颈上皮内瘤变及宫颈癌中的表达及意义探讨 被引量:14

Expression and Signification of p53 and p16 in Cervical Intraepithelial Neoplasia and Cervical Carcinoma.
下载PDF
导出
摘要 目的:探讨p53、p16在宫颈上皮内瘤变及宫颈癌中的表达及临床意义。方法:应用免疫组化SP法检测79例宫颈上皮内瘤变(CIN)、79例宫颈鳞癌和16例正常宫颈组织中p53、p16的表达。结果:在正常宫颈组织、CIN和宫颈鳞癌中p53的阳性率分别为0.00%、47.77%及60.76%,其表达有统计学意义(P<0.01);p16的阳性率分别为0.00%、37.97%及67.09%,其表达有统计学意义(P<0.01)。在CINⅠ、Ⅱ、Ⅲ级组中p53的阳性率分别为24.14%、42.31%及62.50%,有统计学意义(P<0.05);p16的阳性率分别为13.79%、38.46%及66.67%,(P<0.01)。在CIN伴湿疣组p53及p16的阳性表达均高于无湿疣组,但差异无统计学意义(P>0.05)。随宫颈鳞癌病理分级,p16表达上调(P<0.05),而p53表达下调。结论:p53随CIN分级增加而上调,在鳞癌中呈过表达,p53基因突变与宫颈鳞癌的发生、发展有关,尤其是在宫颈鳞癌发生的早期;随宫颈CIN等级增加及宫颈鳞癌分级增加p16表达显著增加,p16标记可作为宫颈CIN分级与鳞癌诊断的重要辅助指标。 Objective: To investigate the expression and signification of p53 and p16 in cervical intraepithelial neoplasia and cervical carcinoma. Methods: Expression of p53 and p16 were detected by immunohistochemistry method in 79 cases of cervical intraepithelial neoplasia (CIN) ,79 esae of cervical squamous cell carcinoma and 16 normal cervical specimens. Results: In normal cervical specimens ,.CIN and cervical squamous cen carcinoma the positive rates of p53 were 0. 00%, 47. 77% and 60. 76%, respectively with significant difference ( P 〈 0. 01 ) ; In CIN I , Ⅱ, Ⅲ the positive rates of p16 were 0. 00%, 37. 97% and 67. 09%, respectively also with significant difference (P 〈0. 01 ). The positive rates of p53 were 24. 14%, 42. 31% and 62.50% ,respectively with significant difference (P 〈0. 05 ) ; the positive rates of p16 were 13. 79%, 38. 46%, and 66. 67% ,respectively with significant difference (P 〈 0. 01 ). The positive rates of p53 and p16 in the those in CIN with condyloma were higher than CIN without condyloma, but without sta- tistic difference (P 〉 0. 05). With cervical squamous cell careinoma' s tumor grades increased the expression of p16 (P 〈 0. 05 ), while the expression of p53 decreased. Conclusion: The expression of p53 increase with CIN grades increase, and shows overexpres- sion in cervical squamous cell carcinoma, the gene mutant of p53 is associated with the pathogenesis and developoment of cervical squamons cell carcinoma, especially in the early stage of pathogenesis. With cervical squamous cell careinima's tumor grades and CIN grades increased,the expression of p16 increases significantly p16 may be an importance in CIN grades and the diagnosis of cervical squamous cell carcinoma.
出处 《肿瘤预防与治疗》 2008年第2期136-139,共4页 Journal of Cancer Control And Treatment
基金 重庆市卫生局科研基金(NO.03-2-006)立项资助
关键词 宫颈上皮内瘤变 宫颈鳞癌 P53 P16 免疫组化 CIN Cervical Squamous Cell Carcinoma p53 p16 Immunohistochemistry
  • 相关文献

参考文献13

  • 1王晓丽,李明众,尚菊战,宋天宝,王梅,王亚莉.P_(53)和bcl-2在宫颈上皮内瘤样变及宫颈癌中的表达[J].中国肿瘤临床与康复,2002,9(2):38-41. 被引量:12
  • 2[2]Hoffman B,Liebermann DA.Molecular controls of apoptosis:differentiation/growth arrest primary response genes,proto-oncogenes,and tumor suppressor genes as positive & negative modulators[J].Oncogene,1994,9:1807-1812.
  • 3[3]Soussi T,Fromentel C,May P,et al.Structure aspects of the p53 protein in relation to gene evolution[J].Oncogene,1990,5:945-952.
  • 4[4]Uurich S,Anderson C,Mercer W,et al.The p53 tumour suppressor protein,a modulator of cell proliferation[J].J Bio Chem,1992,267:15259-15262.
  • 5黄永文,李孟达,吴秋良,刘富元.老年宫颈癌p53和c-erbB2表达及其临床意义[J].癌症,2002,21(3):297-300. 被引量:5
  • 6[6]Avall-Lundqvist EH,Silfversward C,Aspenblad U,et al.The impact of tumour angiogenesis,p53 overexpression and proliferative activity (MIB-1) on survival in squamous cervical carcinoma[J].Eur J Cancer,1997,33(11):1799-1804.
  • 7[7]Kamb A,Gruis NA,Weaver-Feldhaus J,et al.A cell cycle regulatory potentially invlved in genesis of many tumor types[J].Science,1994,264:436-440.
  • 8[8]Shapiro GI,Reciprocal Rb.Inactivation and p16 INK4 eexpression in primary lung cancers and cell lines[J].Cancer Res,1995,55(3):505-509.
  • 9[9]Y,F,Wong MD,Cheng TKH,Cheng TH.p16 INK4 and p15 INK4B alterations in primary gynecologic malignancy[J].Gynecologic Oncology,1997,65:319-324.
  • 10[10]Keating JT,Cviko A,Riethdorf S,et al.Ki-67,cyclin E,and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia[J].Am J Sur Pathol,2001,25(7):884-891.

二级参考文献14

  • 1Cameron RI, Maxwell P, Jenkins D, et al. Immunohistochemical staining with MIB1 ,bc12 and p16 assists in the distiction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia[ J ]. Hi
  • 2Keating JT, Cviko A, Riethdorf S, et al. Ki-67, cyclin E, and P16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia[ J] .Am J Sur Pathol 2001,25(7) :884 - 891.
  • 3Klaes R, Benner A, Friedrich T, et al. p16INK4 immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia[ J]. Am J Surg Pathol,2002,26( 11 ): 1389 - 1399.
  • 4Merrill RM, Feuer EJ. Risk-adjusted cancer-incidence rates (United States) [J]. Cancer Causes Control, 1996, 7(5): 544-552.
  • 5Nakagawa S, Yoshikawa H, Jimbo H, et al. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations [J]. Br J Cancer, 1999, 79: 1139-1144.
  • 6Chang JL, Tsao YP, Liu DW, et al. The expression of type I growth factor receptors in the squamous neoplastic changes of uterine cervix [J]. Gynecol Oncol, 1999, 73: 62-71.
  • 7Jacobs TW, Gown AM, Yaziji H, et al. Specificity of Hercep Test in determining HER-2/neu status of breast cancers using the United States Food and Drug Administration-approved scoring system [J]. J Clin Oncol, 1999, 17:1983-1987.
  • 8Hoffman B, Liebermann DA. Molecular controls of apoptosis: differentiation/growth arrest primary response genes, proto-oncogenes, and tumor suppressor genes as positive & negative modulators [J]. Oncogene, 1994, 9:1807-1812.
  • 9Dittmer D, Pati S, Zambetti G, et al. Gain of function mutations in p53 [J]. Nat Genet, 1993, 4: 42-46.
  • 10Avall-Lundqvist EH, Silfversward C, Aspenblad U, et al. The impact of tumor angiogenesis, p53 overexpression and proliferative activity(MIB-1) on survival in squamous cervical carcinoma [J]. Eur J Cancer, 1997, 33(11): 1799-1804.

共引文献23

同被引文献124

引证文献14

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部